13-month-old receives Dubai's first pediatric liver transplant
In a groundbreaking moment for Dubai's healthcare sector, a 13-month-old child has become the city's first pediatric liver transplant recipient, thanks to a joint effort between King's College Hospital London in Dubai and Al Jalila Foundation.
The complex surgery was led by world-renowned liver transplant specialist Professor Mohamed Rela, and marks a major milestone in Dubai's push for world-class medical care – aligning with the Dubai Social Agenda 33.
The child, Malek, was born with a rare liver disorder known as biliary atresia and was also diagnosed with a congenital heart defect.
Before the transplant could proceed, doctors at Al Jalila Children's Hospital successfully repaired a hole in his heart. His father donated part of his liver, making the life-saving transplant possible.
Malek has since been discharged and is recovering well.
Professor Mohamed Rela – who previously performed a liver transplant on a five-day-old infant, a case recorded in the Guinness World Records as the youngest liver transplant globally – praised the effort as a model of medical excellence and teamwork.
He explained that Malek's condition was particularly complex due to his young age, low weight, and multiple health complications.
He emphasised that the successful outcome highlights the competence of the multidisciplinary medical team and the robustness of the specialised programme, which brings together elite consultants, surgeons, hepatologists, anaesthetists and intensive care experts to deliver holistic care designed to save lives.
Al Jalila Foundation, the philanthropic arm of Dubai Health, signed a cooperation agreement with King's College Hospital London in Dubai during Arab Health 2025.
The agreement aims to expand charitable healthcare initiatives in the UAE by supporting organ transplant programmes.
In a landmark medical breakthrough for the emirate of Dubai and in a testament to the synergy between the public and private healthcare sectors, a medical team at King's College Hospital London in Dubai has successfully performed the city's first liver transplant on a… pic.twitter.com/95erJ7l76I
— Dubai Media Office (@DXBMediaOffice) April 17, 2025
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Al Etihad
2 days ago
- Al Etihad
DHA grants initial approval to Yas Healthcare to set up UAE's first proton therapy centre in Dubai
12 June 2025 18:10 DUBAI (WAM) The Dubai Health Authority (DHA) has accorded initial approval to Yas Healthcare, a subsidiary of Das Holding, to establish the UAE's first proton therapy centre in Dubai, marking a historic milestone in the advancement of cancer care in the region. The state-of-the-art facility is expected to be completed by late 2028, with construction slated to start in early will be the first dedicated centre in the UAE to offer proton therapy, a highly advanced and precise form of radiation therapy that targets tumours with exceptional accuracy while sparing healthy tissue. The treatment is especially effective for paediatric cancers and tumours located near sensitive Dubai Health Authority, Dr. Alawi Alsheikh-Ali, stated, 'Under the visionary leadership of His Highness Sheikh Mohammed bin Rashid Al Maktoum, Vice President and Prime Minister, and Ruler of Dubai, and His Highness Sheikh Hamdan bin Mohammed bin Rashid Al Maktoum, Crown Prince of Dubai, Deputy Prime Minister, Minister of Defence, and Chairman of The Executive Council of Dubai, we are committed to positioning Dubai as a global leader in healthcare. This proton therapy centre will enhance patient care, offering world-class, patient-centred treatment and improving access to specialised care that ensures better outcomes.''This groundbreaking technology will advance cancer treatment options for our community and reinforce Dubai's goal of ranking among the top 10 cities globally for healthy life expectancy. It also strengthens Dubai's position as a key destination for advanced medical care and innovation, in line with the National Strategy for Wellbeing 2031, Dubai Social Agenda 33, and the Dubai Economic Agenda D33.'Proton therapy is a highly precise and advanced radiation treatment that delivers targeted doses to cancerous tumours while sparing surrounding healthy tissue. This minimises side effects and is particularly effective for treating paediatric cancers and complex or sensitive tumour sites. The Yas Proton Therapy Centre will provide patients across the region with access to this specialised treatment for the first time, eliminating the need to travel abroad for project will be developed in strategic collaboration with the National Cancer Centre Singapore (NCCS), one of Asia's leading authorities in oncology. NCCS will serve as the project consultant, bringing global clinical and technical expertise to the design and implementation of the Director and General Manager of Yas Healthcare, Dr. Mohamad Zaki, said, 'Global data indicates a rising number of cancer diagnoses, particularly among younger patients. Proton therapy provides a treatment option with fewer side effects and lower toxicity for certain cancer types. The Yas Proton Therapy Centre aims to improve accessibility and reduce costs by offering this treatment closer to home.'Chair of the Division of Radiation Oncology at the National Cancer Centre Singapore, Dr. Michael Wang, added, 'This milestone collaboration with Yas Healthcare reflects the National Cancer Centre Singapore's leadership in radiation oncology, operating one of the largest proton beam facilities in Southeast Asia. We are excited to contribute our expertise as Yas Healthcare introduces this advanced technology to redefine cancer treatment in the GCC.'The move to develop the new facility directly aligns with the National Strategy for Wellbeing 2031, the Dubai Social Agenda 33, and the Dubai Economic Agenda D33 — key initiatives to enhance quality of life, improve health outcomes, and position Dubai as a premier destination for medical innovation and tourism. Dubai's Medical Tourism Vision also aims to attract more than 500,000 international patients annually by work related to the project is scheduled to begin in early 2026 and the facility is expected to be operational by the end of 2028. Yas Healthcare's official platforms will provide updates on the progress of the project and patient enrolment programmes.
Al Etihad
5 days ago
- Al Etihad
Al Jalila Foundation receives Dh10 million from CBD to support Hamdan Bin Rashid Cancer Hospital
9 June 2025 16:14 DUBAI (WAM) Al Jalila Foundation, the philanthropic arm of Dubai Health, announced a generous Dh10 million donation from Commercial Bank of Dubai (CBD) to support the construction and development of Dubai Health's Hamdan Bin Rashid Cancer Hospital, Dubai's first fully integrated and comprehensive cancer care partnership reflects a shared commitment to advancing human health and underscores the importance of strategic collaboration between national institutions to enhance access to world-class medical services, particularly in the field of donation agreement was signed during an official visit to the Foundation by the Chairman of Commercial Bank of Dubai, Ahmad Abdulkarim Julfar, and the CEO of Al Jalila Foundation, Dr. Amer Al and the accompanying delegation were briefed on the Foundation's core programmes and future signing ceremony was attended by CEO of Dubai Healthcare City, Dr. Amer Sharif, and CEO Emeritus of Al Jalila Children's Hospital,Dr. Abdullah Al said, 'Our support for the Hamdan Bin Rashid Cancer Hospital reflects our deep-rooted commitment to serving the community and supporting individuals in need of advanced medical care. This partnership is aligned with the UAE's longstanding approach to fostering philanthropy in the healthcare sector and upholding the values of compassion and community solidarity.'Dr. Al Zarooni said, 'We thank Commercial Bank of Dubai for its generous contribution to a project that marks a major step forward in Dubai's healthcare landscape. This partnership reflects the power of collaboration in supporting national efforts to enhance cancer care and improve patients' lives.'The 59,000 square metres Hamdan Bin Rashid Cancer Hospital is being developed with the aid of donations received through Al Jalila Foundation, which leads Dubai Health's giving to become a world-class medical institution, the hospital will be equipped with the latest diagnostic and therapeutic technologies and staffed by a highly qualified team of specialist doctors and trained will also play a pioneering role in cancer research and education, focusing on developing innovative treatments and investing in the training of future medical and nursing G+8 floors, the Hamdan Bin Rashid Cancer Hospital was designed with input from cancer survivors to ensure a truly patient-centred hospital was awarded Gold in the Future Healthcare Projects category by World Architecture News. Once operational, it will provide advanced, integrated cancer care to the patients. Al Jalila Foundation continues to forge strategic partnerships with corporations, institutions, and philanthropists to ensure that advanced medical care remains accessible to those in need, while contributing to the nation's vision of a healthier society, aligned with the goals of the Dubai Social Agenda 33.
Zawya
5 days ago
- Zawya
Al Jalila Foundation receives AED 10mln from Commercial Bank of Dubai
Dubai, UAE: Al Jalila Foundation, the philanthropic arm of Dubai Health, announced a generous AED10 million donation from Commercial Bank of Dubai (CBD) to support the construction and development of Dubai Health's Hamdan Bin Rashid Cancer Hospital, Dubai's first fully integrated and comprehensive cancer care facility. This partnership reflects a shared commitment to advancing human health and underscores the importance of strategic collaboration between national institutions to enhance access to world-class medical services, particularly in the field of oncology. The donation agreement was signed during an official visit to the Foundation by H.E. Ahmad Abdulkarim Julfar, Chairman of Commercial Bank of Dubai, and Dr. Amer Al Zarooni, CEO of Al Jalila Foundation. His Excellency and the accompanying delegation were briefed on the Foundation's core programs and future initiatives. The signing ceremony was attended by Dr. Amer Sharif, CEO of Dubai Healthcare City, and Dr. Abdullah Al Khayat, CEO Emeritus of Al Jalila Children's Hospital. H.E. Ahmad Abdulkarim Julfar said: 'Our support for the Hamdan Bin Rashid Cancer Hospital reflects our deep-rooted commitment to serving the community and supporting individuals in need of advanced medical care. This partnership is aligned with the UAE's longstanding approach to fostering philanthropy in the healthcare sector and upholding the values of compassion and community solidarity.' Dr. Amer Al Zarooni, CEO of Al Jalila Foundation, expressed his gratitude: 'We thank Commercial Bank of Dubai for its generous contribution to a project that marks a major step forward in Dubai's healthcare landscape. This partnership reflects the power of collaboration in supporting national efforts to enhance cancer care and improve patients' lives.' The 59,000 square metres Hamdan Bin Rashid Cancer Hospital is being developed with the aid of donations received through Al Jalila Foundation, which leads Dubai Health's giving mission. Set to become a world-class medical institution, the hospital will be equipped with the latest diagnostic and therapeutic technologies and staffed by a highly qualified team of specialist doctors and trained nurses. It will also play a pioneering role in cancer research and education, focusing on developing innovative treatments and investing in the training of future medical and nursing professionals. Spanning G+8 floors, the Hamdan Bin Rashid Cancer Hospital designed with input from cancer survivors to ensure a truly patient-centered environment. The hospital was awarded Gold in the Future Healthcare Projects category by World Architecture News. Once operational, it will provide advanced, integrated cancer care to the patients. Al Jalila Foundation continues to forge strategic partnerships with corporations, institutions, and philanthropists to ensure that advanced medical care remains accessible to those in need, while contributing to the nation's vision of a healthier society, aligned with the goals of the Dubai Social Agenda 33. About Al Jalila Foundation Al Jalila Foundation, that leads Dubai Health's giving mission, is a global healthcare charity transforming lives through medical innovation. Established in April 2013 under the directives of His Highness Sheikh Mohammed bin Rashid Al Maktoum, Vice President and Prime Minister of the UAE and Ruler of Dubai, the foundation works to position Dubai and the UAE at the forefront of medical advancement. The foundation provides essential treatment for those unable to afford healthcare, funds scholarships for medical professionals, and supports pioneering research addressing critical health challenges, including cancer, cardiovascular diseases, diabetes, obesity, and mental health.
